Enzymotec Ltd. Reports Second Quarter 2015 Results

Go back to Enzymotec Ltd. Reports Second Quarter 2015 Results

Wells Fargo Upgrades Enzymotec (ENZY) to Outperform

August 13, 2015 7:36 AM EDT

Wells Fargo upgraded Enzymotec (NASDAQ: ENZY) from Market Perform to Outperform.

For an analyst ratings summary and ratings history on Enzymotec click here. For more ratings news on Enzymotec click here.

Shares of Enzymotec closed at $8.89 yesterday.

... More

Enzymotec (ENZY) Tops Q2 EPS by 5c, Updates FY Guidance

August 12, 2015 7:55 AM EDT

Enzymotec (NASDAQ: ENZY) reported Q2 EPS of $0.11, $0.05 better than the analyst estimate of $0.06. Revenue for the quarter came in at $13.4 million versus the consensus estimate of $12.39 million.

Enzymotec sees FY2015 EPS of $0.28-$0.36, versus the consensus of $0.28. Enzymotec sees FY2015 revenue of $53-59... More